1st Circ. Affirms New Lead Plaintiff Can't Save Biotech Suit
The First Circuit has affirmed a Boston federal court's decision to dismiss a proposed shareholder class action after the investors tried to add a new lead plaintiff into the suit, which...To view the full article, register now.
Already a subscriber? Click here to view full article